Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 10,519 | 80,285 | 160,293 | 13,369 | 27,093 |
| Gross Profit | 10,519 | 80,285 | 160,293 | 13,369 | 27,093 |
| Operating Expenses | 65,893 | 65,530 | 38,841 | 50,176 | 49,182 |
| Operating Income | -55,374 | 14,755 | 121,452 | -36,807 | -22,089 |
| Interest Expense | -3,252 | 328 | -1,025 | 321 | 560 |
| Other Income | 149 | 36,430 | -3,835 | 1,862 | 1,086 |
| Pre-tax Income | -51,973 | 50,857 | 118,642 | -35,266 | -21,563 |
| Income Tax | 577 | 103 | N/A | N/A | N/A |
| Net Income Continuous | -52,550 | 50,754 | 117,347 | -35,266 | -21,563 |
| Net Income | $-52,550 | $50,754 | $117,347 | $-35,266 | $-21,563 |
| EPS Basic Total Ops | -1.98 | 1.91 | 4.44 | -1.33 | -0.82 |
| EPS Basic Continuous Ops | -1.98 | 1.91 | 4.44 | -1.33 | -0.82 |
| EPS Diluted Total Ops | -1.98 | 1.87 | 4.44 | -1.33 | -0.82 |
| EPS Diluted Continuous Ops | -1.98 | 1.87 | 4.43 | -1.33 | -0.82 |
| EPS Diluted Before Non-Recurring Items | -1.98 | 0.88 | 4.33 | N/A | N/A |
| EBITDA(a) | $-54,637 | $15,333 | $122,003 | $-36,390 | $-21,754 |